Biology & drug discovery · London, UK · founded 2021
Isomorphic Labs: who founded it, who funds it
Isomorphic Labs is a London AI drug discovery lab founded in 2021 by Demis Hassabis, who came from DeepMind. What it is building: drug discovery beyond AlphaFold; an Alphabet subsidiary with pharma partnerships. It has raised $600M in disclosed rounds, most recently a Series A of $600M in March 2025, led by Thrive Capital. Its work reaches customers through partnerships rather than a public product.
- Founders
- Demis Hassabis (ex-Google DeepMind)
- Founders from
- ex-Google DeepMind
- Location
- London, UK (Europe)
- Valuation
- ·
- Raised
- $600M disclosed
- Investors
- Thrive Capital lead, GV (Google Ventures), Google
- What ships
- Partnerships
- In talks
- at $40B Oct 8, 2026. Bloomberg: talks at a valuation of at least $40B; SiliconANGLE reports up to $50B source
Rounds
| Date | Round | Amount | Valuation | Lead | Source |
|---|---|---|---|---|---|
| Mar 31, 2025 | Series A | $600M | · | Thrive Capital | neolabs.fyi |
Sources
- neolabs.fyi neolabs.fyi
News
-
Oct 8, 2026
+3 more coverage
- SiliconANGLE Alphabet spinoff Isomorphic Labs reportedly raising funding at up to $50B valuation
- Bloomberg.com Watch Google DeepMind's AI Drug Spinoff, Isomorphic Labs, Seeks Funding at Valuation of $…
- Bloomberg.com Watch Isomorphic Labs' $40B Valuation; WHO Urges Russia Plague Transparency
Investors who back other labs here
- Google also: Safe Superintelligence, Ineffable Intelligence, Sakana AI, Essential AI
- Thrive Capital also: Physical Intelligence, Essential AI, Chai Discovery
- GV (Google Ventures) also: Recursive Superintelligence, Humans&
Same research area
- Chai Discovery $3.8B · San Francisco, US
- Merge Labs $850M · San Francisco, US
- EvolutionaryScale · · New York, US
- Latent Labs · · London, UK
- Xaira Therapeutics · · South San Francisco, US